
Abbott Labs (ABT) Stock Forecast & Price Target
Abbott Labs (ABT) Analyst Ratings
Bulls say
Abbott Laboratories is well positioned to capitalize on the global growth of the cardiovascular and diabetes device markets, thanks to its diverse portfolio of high-quality products and its focus on expanding its presence in key regions outside of the United States. The company's innovative commercial strategy, supported by a competitive portfolio and a focus on affordability, should continue to drive market share gains in the rapidly growing electrophysiology market. Additionally, Abbott's diversified business model, strong financials and ongoing success in launching new products make it a compelling investment opportunity.
Bears say
Abbott Laboratories is facing a number of challenges, including rapid technological changes and intense competition in the medical devices and diagnostics market. Despite the company's investments in new product launches and expanding its biosimilars portfolio, the negative impact of a weaker-than-expected respiratory season and lower growth expectations in several key business segments may hinder its ability to sustain its growth trajectory and meet its sales outlook. With global sales accounting for a significant portion of revenue, Abbott may also face currency fluctuations and other macroeconomic risks that could negatively affect its financial performance.
This aggregate rating is based on analysts' research of Abbott Labs and is not a guaranteed prediction by Public.com or investment advice.
Abbott Labs (ABT) Analyst Forecast & Price Prediction
Start investing in Abbott Labs (ABT)
Order type
Buy in
Order amount
Est. shares
0 shares